Bleach maker Clorox's Q2 revenue beats estimates

Reuters
02/04
Bleach maker Clorox's <a href="https://laohu8.com/S/QTWO">Q2</a> revenue beats estimates

Overview

  • Consumer goods firm's fiscal Q2 revenue beat analyst expectations despite a 1% decline

  • Adjusted EPS for fiscal Q2 missed analyst expectations

Outlook

  • Clorox maintains fiscal year 2026 net sales outlook to decrease 6% to 10%

  • Company expects fiscal year 2026 adjusted EPS between $5.95 and $6.30

  • Clorox anticipates GOJO acquisition to close before fiscal year-end 2026

Result Drivers

  • LOWER CONSUMPTION - Net sales decreased 1% due to lower consumption, partially offset by shipments ahead of consumption

  • HIGHER COSTS - Gross margin decreased due to higher manufacturing and logistics costs, partially offset by cost savings

  • DIGITAL INVESTMENTS - Lower costs related to digital capabilities and productivity enhancements impacted EPS

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$1.67 bln

$1.64 bln (13 Analysts)

Q2 Adjusted EPS

Miss

$1.39

$1.43 (15 Analysts)

Q2 EPS

$1.29

Q2 Gross Margin

43.2%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 14 "hold" and 4 "sell" or "strong sell"

  • The average consensus recommendation for the household products peer group is "buy."

  • Wall Street's median 12-month price target for Clorox Co is $115.00, about 1.5% above its February 2 closing price of $113.29

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nPn9h7D65a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10